The Week

Teradyne (TER) finished the week sharply lower, shedding 10.28% to close at $375.74, while the S&P 500 dipped just 1.43% — underperforming the benchmark by roughly 8.85 percentage points. The swing was violent: the stock rallied to a midweek high of $444.17 on Monday before reversing hard. Tuesday and Wednesday saw heavy selling, with the stock touching an intraweek low of $365.01, leaving a full-week range of 18.63%. A modest bounce on Thursday was followed by another leg down on Friday, leaving the price near the bottom of the week’s band. Trading volume totalled 14.1m shares, about 20% below the 60-day median daily pace.

Key Events

The week’s sell-off appeared to crystallise around news from subsidiary LitePoint. On Tuesday, LitePoint confirmed it had collaborated with STMicroelectronics to validate its next-generation UWB chip family. Instead of cheering the update, the market took it as a cue to lock in profits — Teradyne slid as much as 7% intraday Tuesday and accelerated to a 10% drop on Wednesday, with investors seemingly unimpressed by the near-term revenue implications. Earlier in the week, a media piece framing Teradyne against Micron in the AI trade helped push the stock higher on Monday, but the gains were quickly erased. A small insider sale — director Marilyn Matz offloaded 1,200 shares for $510,000 — added to the cautious tone, though the size was modest.

Analyst Ratings

Despite the steep pullback, the sell-side consensus remains constructive. Of 19 brokers covering the stock, 12 rate it buy or overweight (11 buys, 1 overweight), 5 are at hold, and 2 have no opinion — none carry a sell or underweight. The consensus recommendation is buy, and the consensus target stands at $449.80, implying about 19.7% upside from the week’s close. The target range, however, is unusually wide: from $350 to $550, pointing to a fair amount of disagreement on the path ahead. Within the semiconductor materials and equipment industry, Teradyne’s ranking sits in the upper-middle tier among 31 peers.

The Week Ahead

A batch of US housing and consumer data lands on Tuesday, 25 August. The FHFA house price index and the S&P CoreLogic Case-Shiller 20-city index will be released alongside August consumer confidence and new home sales. If housing data comes in softer than expected, it could reinforce fears that macro demand is cooling, which would weigh on a cyclical name like Teradyne. The stock’s sharp move this week also raises the question of whether institutional money will start repositioning at these lower levels.

In Short

Teradyne’s week was a textbook profit-taking event triggered by a product validation update that the market chose to shrug off. The sell-off pushed the stock below both its 20-day and 60-day moving averages. At roughly 51x earnings and 17x book value, the multiple is not cheap, yet the broker consensus target still points to meaningful upside — setting up the central tension in the name right now. Large-lot flow on the latest trading day was modestly net positive, but medium and small orders tilted to the net selling side, suggesting retail and smaller institutional players were taking risk off the table. The near-term debate hinges on whether the next round of macro data confirms or soothes the growth concerns that rattled this week’s holders.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.